FDA Drug Application (076711) for BUPROPION HYDROCHLORIDE by IMPAX LABS

Back to FDA Applications sponsored by IMPAX LABS

Application Number076711
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBUPROPION HYDROCHLORIDE
Active IngredientBUPROPION HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPROPION HYDROCHLORIDE7


Back to FDA Applications sponsored by IMPAX LABS